HMOX1 and colitis: CA has been shown to activate the Nrf-2/HO-1 pathway in DSS-treated mice, upregulate the expression of anti-inflammatory cytokines, antioxidant enzymes, and gut-tight junction proteins, and alleviate colitis (39).